Nova Patents
LU92484I2

Combinations and modes of administration of therapeutic agents and combination therapy

Abstract

Provided herein is a composition comprising nanoparticles comprising paclitaxel and an albumin for use in a method for the treatment of cancer in an individual, wherein the method further comprises administering an antimetabolite.

Term

7.7 yearsto projected expiry

Projected expiry 18 June 2034, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

177 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
65424505United States of AmericaP
2006006167United States of AmericaW

Members177

Family members, oldest first
DocumentOfficeKind
AU2006213999A1AustraliaA1
CA2598239A1CanadaA1
CA2902071A1CanadaA1
CA3054535A1CanadaA1
WO2006089290A1World Intellectual Property Organization (WIPO)A1
US2006263434A1United States of AmericaA1
US2007116774A1United States of AmericaA1
US2007166388A1United States of AmericaA1
EP1853250A1European Patent Office (EPO)A1
KR20070114753ARepublic of KoreaA
IL185288D0IsraelD0
MX2007009960AMexicoA
US2008063724A1United States of AmericaA1
CN101160123AChinaA
AU2007317859A1AustraliaA1
CA2668607A1CanadaA1
WO2008057562A1World Intellectual Property Organization (WIPO)A1
HK1109589A1Hong Kong, ChinaA1
JP2008530248AJapanA
ZA200707491BSouth AfricaB
HK1119071A1Hong Kong, ChinaA1
RU2007134571ARussian FederationA
US2009098210A1United States of AmericaA1
BRPI0607809A2BrazilA2
MX2009004803AMexicoA
NO20092179LNorwayL
KR20090087906ARepublic of KoreaA
EP2097078A1European Patent Office (EPO)A1
CN101573108AChinaA
US2009304805A1United States of AmericaA1
IL198576D0IsraelD0
JP2010509331AJapanA
NZ560879ANew ZealandA
US2010112077A1United States of AmericaA1
US7758891B2United States of AmericaB2
US7780984B2United States of AmericaB2
ZA200903132BSouth AfricaB
RU2009121568ARussian FederationA
SG166775A1SingaporeA1
EP2301531A2European Patent Office (EPO)A2
EP2301531A3European Patent Office (EPO)A3
US8034375B2United States of AmericaB2
EP1853250B1European Patent Office (EPO)B1
AT531365TAustriaT
ATE531365T1AustriaT1
DK1853250T3DenmarkT3
SI1853250T1SloveniaT1
PT1853250EPortugalE
ES2375828T3SpainT3
PL1853250T3PolandT3
AU2006213999B2AustraliaB2
AU2012201568A1AustraliaA1
RU2452482C2Russian FederationC2
NZ576856ANew ZealandA
US2012177743A1United States of AmericaA1
EP2481405A1European Patent Office (EPO)A1
IL220547D0IsraelD0
US8257733B2United States of AmericaB2
US8268348B2United States of AmericaB2
JP2012193205AJapanA
NZ595313ANew ZealandA
JP2013064014AJapanA
AU2013204181A1AustraliaA1
AU2013204188A1AustraliaA1
AU2013204198A1AustraliaA1
HK1173976A1Hong Kong, ChinaA1
CN103169729AChinaA
CN101160123BChinaB
AU2007317859B2AustraliaB2
US2013195922A1United States of AmericaA1
US2013195984A1United States of AmericaA1
US2013209518A1United States of AmericaA1
RU2012106620ARussian FederationA
CN103285395AChinaA
BRPI0718528A2BrazilA2
US2014017315A1United States of AmericaA1
US2014023717A1United States of AmericaA1
KR20140016402ARepublic of KoreaA
JP2014043454AJapanA
US2014079793A1United States of AmericaA1
EP2097078B1European Patent Office (EPO)B1
DK2097078T3DenmarkT3
US8735394B2United States of AmericaB2
ES2469716T3SpainT3
PT2097078EPortugalE
AU2012201568B2AustraliaB2
SI2097078T1SloveniaT1
PL2097078T3PolandT3
JP2014224157AJapanA
US2015079177A1United States of AmericaA1
KR20150043560ARepublic of KoreaA
RU2013149282ARussian FederationA
KR20150065957ARepublic of KoreaA
US9101543B2United States of AmericaB2
JP5769358B2JapanB2
JP2015155454AJapanA
CN104940929AChinaA
LU92484I2This recordLuxembourgI2
JP2016014073AJapanA
CN105288630AChinaA
Showing 100 of 177